Table VII.
Treatment (n=17) | Placebo (n=15) | P-value | |
---|---|---|---|
ALT, IU/la | 23.65±8.48 | 21.00±9.36 | 0.408 |
AST, IU/la | 20.00±4.03 | 19.20±4.00 | 0.578 |
r-GT, U/la | 40.35±42.09 | 21.67±16.53 | 0.106 |
BUN, mg/dlb | 12.90 (3.59) | 12.50 (4.01) | 0.866 |
Creatinine, mg/dla | 0.75±0.14 | 0.75±0.16 | 0.994 |
Iron, mg/dla | 103.24±38.52 | 107.00±41.01 | 0.791 |
Ferritin, ng/mla | 166.98±106.01 | 183.61±105.83 | 0.661 |
WBC, 103/mm3 b | 5.92 (2.35) | 5.42 (1.59) | 0.202 |
RBC, million/mm3 b | 5.06 (0.49) | 4.85 (0.70) | 0.538 |
Hb, g/dlb | 15.20 (1.40) | 14.80 (1.90) | 0.549 |
Hct, %b | 43.50 (3.10) | 42.70 (5.70) | 0.955 |
DHEA, ng/mlb | 207.30 (105.30) | 236.10 (161.00) | 0.575 |
Testosterone, ng/mla | 14.77±48.02 | 3.11±2.07 | 0.332 |
Estradiol, ng/mla | 37.65±10.40 | 56.33±33.13 | 0.052 |
Mean ± standard deviation
median (interquartile range). ALT, alanine aminotranferease; AST, aspartate aminotransferase; r-GT, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; DHEA, dehydroepiandrosterone.